NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells

Molecular Reproduction and Development

Volumn 48, Issue 3, 1997, Pages 301-309

  Lamb, Kimberly A ^a,b   Johnson, Lance R ^a,b   Rizzino, Angie ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cis regulatory element; Embryonal carcinoma; Embryonic stem; Fibroblast growth factor; Gel mobility shift analysis

Indexed keywords

FIBROBLAST GROWTH FACTOR 4;

ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING;

ANIMALS; BINDING, COMPETITIVE; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; MICE; NUCLEAR PROTEINS; PLASMIDS; PROTO-ONCOGENE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

MAMMALIA;

EID: 0030767478     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199711)48:3<301::AID-MRD1>3.0.CO;2-V     Document Type: Article

References (63)

1. Bryans M, Lucas J, Knobloch T, Wilkie N, Lang J ( 1995): Regulation of FGF-4 of enhancer activity by transcription factor NF-Y. Biochem Biophys Res Commun 211:519-527.
2. Bucher P (1990): Weight matrix description of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 212:563-578.
3. Chan D, Wynshaw-Boris A, Leder P (1995): Formin isoforms are differentially expressed in mouse embryo and are required for normal expression of FGF-4 and shh in the limbbud. Development 121:3151-3162.
4. Chodosh LA, Baldwin AS, Carthew RW, Sharp PA (1988): Human CCAAT-binding proteins have heterologous subunits. Cell 53:11-24.
5. Curatola AM, Basilico C (1990): Expression of the K-fgf proto-oncogene is controlled by 3′ regulatory elements which are specific for embryonal carcinoma cells. Mol Cell Biol 10:2475-2484.
6. Dailey L, Yuan H, Basilico C (1994): Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol Cell Biol 14:7758-7769.
7. Davis LG, Dibner MD, Battey JF (1986): Calcium phosphate transfection of nonadherent and adherent cells with purified plasmids. In "Basic Methods in Molecular Biology." New York: Elsevier, pp. 286-289.
8. Dignam JD, Lebovitz RM, Roeder RG (1983): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
9. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R (1985): The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morph 87:27-45.
10. Feldman B, Poueymirou W, Papaiannou VE, DeChiara TM, Goldfarb M (1995): Requirement of FGF-4 for postimplantation mouse development. Science 267:246-249.
11. Fried M, Crothers DM (1981): Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6505-6525.
12. Hasan S, Koda T, Kakinuma M (1994): An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J Biol Chem 269:25042-25048.
13. Hatamochi A, Golumbek PT, Van Schaftingen E, de Crombrugghe B (1988): A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding. J Biol Chem 263:5940-5947.
14. Heath JK, Isacke CM (1984): PC13 embryonal carcinoma-derived growth factor. EMBO J 3:2957-2962.
15. Hinkley C, Perry M (1992): Histone H2B gene transcription during xenopus early development requires functional cooperation between proteins bound to the CCAAT and octamer motifs. Mol Cell Biol 12:4400-4411.
16. Hooft van Huijsduijnen R, Bollekens J, Dorn A, Benoist C, Mathis D (1987): Properties of a CCAAT box-binding protein. Nucleic Acids Res 15:7265-7272.
17. Jackson SM, Ericson J, Osporn TF, Edwards PA (1995): NF-Y has a novel role in sterol-dependent transcription of two cholesterogenic genes. J Biol Chem 270:21445-21448.
18. Kelly D, Scholtz B, Orten D, Hinrichs S, Rizzino A (1995): Regulation of the transforming growth factor-β2 gene promoter in embryonal carcinoma cells and their differentiated cells: Differential utilization of transcription factors. Mol Reprod Dev 40:135-145.
19. Kim CG, Sheffery M (1990): Physical characteristics of the purified CCAAT transcription factor α-CP-1. J Biol Chem 265:13362-13369.
20. Koda T, Hasan S, Sasaki A, Arimura Y, Kakinuma M (1994): Regulatory sequences required for hst-1 expression in embryonal carcinoma cells. FEBS Lett 342:71-75.
21. Lamb K, Rosfjord E, Brigman K, Rizzino A (1996): Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene. Mol Reprod Dev 44:460-471.
22. Li X-Y, Mantovani R, Hooft van Huijsduijnen R, Andre I, Benoist C, Mathis D (1992): Evolutionary variation of the CCAAT-binding transcription factor NF-Y. Nucleic Acids Res 20:1087-1091.
23. Lickteig K, Lamb K, Brigman K, Rizzino A (1996): Effects of oxidation and reduction on the binding of transcription factors to cis-regulatory elements in the FGF-4 gene. Mol Reprod Dev 44:146-152.
24. Ma Y-G, Rosfjord E, Huebert C, Wilder P, Tiesman J, Kelly D, Rizzino A (1992): Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev Biol 154:45-54.
25. Maity SN, Golumbeck PT, Karsenty G, de Crombrugghe B (1988): Selective activation of transcription by a novel CCAAT binding factor. Science 241:582-585.
26. Maity SN, Sinha S, Ruteshouser EC, De Crombrugghe B (1992): Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem 267:16574-16580.
27. Mantovani R, Pessara U, Tronche F, Li X-Y, Pasquali J-L, Benoist C, Mathis D (1992): Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J 11:3315-3322.
28. Mantovani R, Li X-Y, Pessara U, Hooft van Huisjduijnen R, Benoist C, Mathis C (1994): Dominant negative analogs of NF-YA. J Biol Chem 269:20340-20346.
29. Miller K, Rizzino A (1994): Developmental regulation and signal transduction pathways of fibroblast growth factors and their receptors. In M Nilsen-Hamiliton (ed): "Growth Factors and Signal Transduction in Development." New York: Wiley-Liss, pp 19-49.
30. Milos PM, Zaret KS (1992): A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. Genes Dev 6:2497-2509.
31. Niswander L, Martin G (1992): FGF-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114:755-768.
32. Niswander L, Tickle C, Vogel A, Martin G (1994): Function of FGF-4 in limb development. Mol Reprod Dev 39:83-89.
33. Ochiya T, Sakamoto H, Tsukamoto M, Sugimura T, Terada M (1995): Hst-1 (FGF-4) antisense oligonucleotides block murine limb development. J Cell Biol 130:997-1003.
34. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H (1990): A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
35. Okazawa H, Okamoto K, Ishino F, Ishino-Kaneko T, Takeda S, Toyoda Y, Muramatsu M, Hamada H (1991): The Oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressive enhancer. EMBO J 10:2997-3005.
36. Peters G, Brookes S, Smith R, Placzek M. Dickson C (1989): The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci USA 86:5678-5682.
37. Rappolee DA, Sturm K, Schultz G, Pedersen R, Werb Z (1990): Expression of growth factor ligands and receptors in preimplantation mouse embryos. In S Heyner, E Wiley (eds): "Early Embryo Development and Paracrine Relationships." New York: Wiley-Liss, pp 11-25.
38. Reith W, Siegrist C-A, Durand B, Mach B (1994): Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci USA 91:554-558.
39. Rizzino A (1989): Use of embryonal carcinoma cells to study growth factors during early mammalian development. In IY Rosenblum, S Heyner (eds): "Growth Factors in Mammalian Development." Boca Raton, FL: CRC Press, pp 113-134.
40. Rizzino A, Rosfjord E (1994): Transcriptional regulation of the murine k-fgf gene. Mol Reprod Dev 39:106-111.
41. Rizzino A, Orme LS, De Larco JE (1983): Embryonal carcinoma cell growth and differentiation: Production of and response to molecules with transforming growth factor activity. Exp Cell Res 143:143-152.
42. Rizzino A, Kuszynski C, Ruff E, Tiesman J (1988): Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev Biol 129:61-71.
43. Rosfjord E, Lamb K, Rizzino A (1994): Cryptic promoter activity within the backbone of a plasmid commonly used to prepare promoter/ reporter gene constructs. In Vitro Cell Dev Biol 30A:477-481.
44. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PWJ, Staudt LM (1990): A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
45. Schöler HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P (1989): A family of octamer-specific proteins present during mouse embryogenesis: Evidence for germline-specific expression of an Oct factor. EMBO J 8:2543-2550.
46. Scholtz B, Lamb K, Rosfjord E, Kingsley M, Rizzino A (1996a): Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation. Dev Biol 173:420-427.
47. Scholtz B, Kingsley-Kallesen M, Rizzino A (1996b): Transcription of the transforming growth factor-β2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene. J Biol Chem 271:32375-32380.
48. Schoorlemmer J, Kruijer W (1991): Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells. Mech Dev 36:75-86.
49. Seed B, Sheen JY (1988): A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67:271-277.
50. Sinha S, Maity SN, Lu J, De Crombrugghe B (1995): Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-C and with yeast HAP2 and HAP3. Proc Natl Acad Sci USA 92:1624-1628.
51. Smallwood PM, Munoz-Sanjuan I, Tong P, Macke JP, Hendry SHC, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J (1996): Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 93:9850-9857.
52. Tiesman J, Rizzino A (1989): Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells. In Vitro Cell Dev Biol 25:1193-1198.
53. Tiesman J, Rizzino A (1990): Nucleotide sequence of the 5′ flanking region of the k-FGF oncogene exhibits an alternating purine: pyrimidine motif with the potential to form Z-DNA. Gene 96:311-312.
54. Tronche F, Rollier A, Sourdive D, Cereghini S, Yaniv M (1991): NFY or a related CCAAT binding factor can be replaced by other transcriptional activators for cooperation with HNF1 in driving rat albumin promoter in vivo. J Mol Biol 221:31-43.
55. Velcich A, Delli-Bovi P, Mansukhani A, Ziff EB, Basilico C (1989): Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res 5:31-37.
56. Wright KL, Vilen BJ, Itoh-lindstrom Y, Moore TL, Li G, Criscitiello M, Cogswell P, Clarke JB, Ting JP-Y (1994): CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J 13:4042-1053.
57. Wright KL, Moore TL, Vilen BJ, Brown AM, Ting JP-Y (1995): Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J Biol Chem 270:20978-20986.
58. Wuarin J, Meuller C, Schibler U (1990): A ubiquitous CCAAT factor is required for efficient in vitro transcription from the mouse albumin promoter. J Mol Biol 214:865-874.
59. Yamasaki M, Miyake A, Tagashira S, Itoh N (1996): Structure and function of the rat mRNA encoding a novel member of the fibroblast growth factor family. J Biol Chem 271:15918-15921.
60. Yoshida T, Miyagawak K, Odagiri H, Sakamoto H, Little PF, Terada M, Sugimura T (1987): Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoding protein. Proc Natl Acad Sci USA 84:7305-7309.
61. Yoshida T, Muramatsu H, Muramatsu T, Sakamoto H, Katoh O, Sugimura T, Terada M (1988): Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells. Biochem Biophys Res Commun 157:618-625.
62. Yuan H, Corbi N, Basilico C, Dailey L (1995): Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 9:2635-2645.
63. Zeleznik-Le NJ, Azizkhan JC, Ting JP-Y (1991): Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 88:1873-1877.